OSTEOPATHIC MEDICINE SUPPORTIVE CARE IN PEDIATRIC

J
Jenny Belsky, DO

Primary Investigator

Enrolling By Invitation
2-30 years
All
Phase N/A
30 participants needed
2 Locations

Brief description of study

What is the purpose of this study?
The purpose of this study is to find compare therapy side effects with a treatment called osteopathic manipulative treatment to standard of care medicines without osteopathic manipulative treatment. Osteopathic medicine is a distinct form of medical practice that offers the added benefit of hands-on diagnoses and treatment. Osteopathic manipulative treatment (OMT) incorporates hands-on techniques such as gentle stretching, to targeting specific muscle and nerve groups. Studies suggest that osteopathic medicine in patients could reduce pain, nausea and vomiting, constipation, and cost of hospitalizations, as well as improve quality of life. This information may be used to start using osteopathic manipulative treatment with your current medicines.

Only eligible patients that have been referred by a physician or self-referred to and seen by section of Pediatric Hematology/Oncology staff will be invited to participate in the clinical trial. Potential subjects will be contacted in the hospital or at a clinic visit in Pediatric Hematology/Oncology.

THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with most oncology trials, patients are not actively “recruited,” but are screened by their physician for appropriate clinical trial(s) at the time of their routine clinic visit. Occasionally, a patient may be a self-referral or physician referral, but are still screened for appropriate clinical trials at the time of their routine clinic visit. PI and staff may send copies of relevant consent forms to these patients to look over prior to actually consenting or enrolling them. This may take place at the patient's visit at which the consent is presented or the patient's next visit to the outpatient hematology/oncology clinic.

Interested in participating? For more information about this research study or other cancer-related clinical trials at IU Simon Comprehensive Cancer Center, please contact:
IU Clinical Trials Office 
Phone: (317) 278-5632

Detailed description of study

What will happen during the study?
  • Validated survey tools will be used to assess pain, constipation, and neuropathy. 
  • Non-validated qualitative questions will be used to assess patient and caregiver perceptions of OMT.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Cancer, Riley
  • Age: Between 2 Years - 30 Years
  • Gender: All

Inclusion criteria
1)    Confirmed diagnosis of cancer or SCD
2)    Patients aged >2 years to < 30 years
3)    Caregiver must have the ability to understand and the willingness to sign a written informed consent document in English, due to survey availability in English only

Exclusion criteria
1)    Prior malignancy or pre-existing condition including but not limited to inflammatory bowel disease, diabetes, chronic pain syndromes, chronic neuropathic pain, trisomy 21 and additional genetic conditions are excluded due to confounding variables
2)    Patients with a significant illness that is not covered by the exclusion criteria or that is expected to interfere with the action of study treatment are not eligible
3)    Pregnant or breastfeeding women, due to lack  of data of OMT in this patient population 

Updated on 09 Sep 2024. Study ID: PHO-IIR-OSTEOPATHICMEDICINE, 11059
Please visit our main page to search for other studies you may be interested in. If you need help finding a study or have any questions, please contact us at inhealth@iu.edu

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center